En Es
Categories

Industry News

Philips lanza un programa emergente de colaboración en IA

By Medimaging en español staff writers
07 Nov 2018

Imagen: El nuevo programa de inteligencia artificial se enfoca en la aplicación de herramientas de soporte de decisiones clínicas y de flujo de trabajo basadas en la inteligencia artificial (Fotografía cortesía de iStock).Royal Philips (Ámsterdam, Países Bajos) lanzó su primer programa global de colaboración emergente que involucra los centros de innovación de la compañía en Cambridge, EUA, Eindhoven, Países Bajos, Bangalore, India y Shanghái, China, centrados en la aplicación. de inteligencia artificial (IA) en salud. El programa se centra en la aplicación de herramientas de apoyo a la toma de decisiones clínicas basadas en la IA, como la interpretación, el análisis y la integración de imágenes, y las herramientas de flujo de trabajo, como los planes de tratamiento inteligente para radiología, ultrasonido y oncología.

Philips pretende utilizar una combinación de inteligencia artificial y otras tecnologías con conocimiento del contexto clínico y operacional en el que se utilizan, un enfoque centrado en las personas al que se refiere como "inteligencia adaptativa". Su objetivo es desarrollar soluciones integradas que se adapten a las necesidades de los proveedores de atención médica y que estén integradas en sus flujos de trabajo. Para respaldar la adopción de la inteligencia artificial en los dominios clave de la atención médica, Philips ha desarrollado una plataforma de inteligencia artificial para la asistencia médica: Philips HealthSuite Insights, que proporciona herramientas y tecnologías específicas de la asistencia médica para abordar el proceso completo de creación, mantenimiento, implementación y escalado de soluciones de inteligencia artificial. Las herramientas y tecnologías disponibles a través de HealthSuite Insights ya permiten el aprendizaje automático y las aplicaciones de aprendizaje profundo en las soluciones de diagnóstico por imágenes de Philips, las soluciones de telesalud y las ofertas de oncología y genómica.

Philips ha extendido sus programas de colaboración a empresas de tecnología de la salud y actividades de capital de riesgo. Philips HealthWorks acelera la innovación de vanguardia a través del compromiso de emprendimiento interno participación externa de la empresa emergente. El programa permite a Philips evaluar, fomentar y monitorizar las prometedoras empresas emergentes en sus primeras etapas para posibles colaboraciones futuras, así como proporcionar a la compañía una visión detallada de los desarrollos más recientes en tecnología de la salud en todo el mundo.

De los 750 solicitantes, Philips ha seleccionado las 19 empresas emergentes más prometedoras para incluirlas en el programa de incubadoras para empresas nuevas. Durante el programa intensivo de 12 semanas 'IA en la atención de salud para Radiología, Ultrasonido y Oncología', Philips se involucrará simultáneamente con las empresas emergentes de 14 países diferentes, con el fin de validar sus propuestas, ayudar a construir, probar y escalar sus ideas, y explorar posibles colaboraciones. Las nuevas empresas seleccionadas se beneficiarán de los conocimientos y la experiencia de Philips en el campo de la atención médica profesional, y obtendrán acceso a la experiencia en el ecosistema de innovación de la empresa, que incluye socios de hospitales, académicos, industriales y financieros.

"En Philips, usamos tecnología inteligente para mejorar la salud de las personas en todo el proceso de salud, desde una vida saludable y la prevención hasta el diagnóstico, el tratamiento y la atención domiciliaria, al mismo tiempo que aumentamos la eficiencia de la prestación de atención médica", dijo Alberto Prado, director de Philips Healthworks. "Ya trabajamos estrechamente con socios clínicos para desarrollar soluciones habilitadas para la IA que se basan en la investigación científica y se validan en la práctica clínica. Este nuevo programa de colaboración reconoce el papel que desempeñan las empresas de nueva creación para llevar al mercado innovaciones de vanguardia en el sector de la salud".

Enlace relacionado:
Royal Philips



E-mail Print
FaceBook Twitter Google+ Linked in

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare with a strong presence in cardio-pulmonary, oncology and women’s health
More info

More articles about Philips Healthcare

09 Nov 2021
Philips Acquires Medical Technology Company Cardiologs to Expand Cardiac Diagnostics and Monitoring Portfolio
Royal Philips (Amsterdam, the Netherlands) has signed an agreement to acquire Cardiologs (Paris, France), a medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology.
Read More
13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
09 Mar 2021
Philips' Diagnostic X-ray Suite to Incorporate Lunit's AI Software
Philips Healthcare (Amsterdam?, the Netherlands) has entered into a collaboration with Lunit (Seoul, Korea) that will make Lunit's AI software accessible to users of Philips' diagnostic X-ray solutions.
Read More
20 Jan 2021
Philips Acquires Capsule Technologies to Expand Leadership in Patient Care Management Solutions for Hospitals
Royal Philips (Amsterdam, the Netherlands) has signed an agreement to acquire Capsule Technologies, Inc. (Andover, MA, USA), a provider of medical device integration and data technologies for hospitals and healthcare organizations.
Read More
10 Mar 2020
Philips Receives Global AI for Enhanced Radiology Interpretation Company of The Year Award from Frost & Sullivan
 Philips Healthcare (Amsterdam?, Noord-Holland) has been recognized with the 2019 Global Company of the Year Award by Frost & Sullivan, based on its recent analysis of the global market for Artificial Intelligence (AI) for enhanced radiology interpretation market. Each year, Frost & Sullivan presents a Company of the Year award to the organization that demonstrates excellence in terms of growth strategy and implementation in its field. The award recognizes a high degree of innovation with products and technologies, and the resulting leadership in terms of customer value and market penetration.
Read More
05 Apr 2019
Philips Acquires Direct Radiology Teleradiology Platform
Royal Philips is expanding its radiology solutions portfolio with innovative teleradiology services, aimed at addressing the increasing shortage of radiologists, as well as the pressing need to improve access to precision diagnoses.
Read More
30 Oct 2018
Philips Launches Start-Up AI Collaboration Program
Royal Philips has launched its first global start-up collaboration program involving the company’s innovation hubs in Cambridge, US, Eindhoven, the Netherlands, Bangalore, India and Shanghai, China focused on the application of artificial intelligence (AI) in healthcare. The program focuses on the application of AI-based clinical decision support tools, such as image interpretation, analysis and integration, and workflow tools, such as intelligent treatment plans for radiology, ultrasound and oncology.
Read More
22 Aug 2018
Intel and Philips Partner to Speed Up Imaging Analysis Using AI
Intel Corporation and Royal Philips have tested two healthcare use cases for deep learning inference models: one on X-rays of bones for bone-age-prediction modeling and the other on CT scans of lungs for lung segmentation. In these tests, which were conducted using Intel Xeon Scalable processors and the OpenVINO toolkit, the researchers achieved a speed improvement of 188 times for the bone-age-prediction model and 38 times for the lung-segmentation model over the baseline measurements. These tests show that healthcare organizations can implement artificial intelligence (AI) workloads without expensive hardware investments.
Read More

Additional news

27 Jun 2022
Robot-Assisted Surgical Devices Market Driven by Increased Demand for Patient-Specific Surgeries
Given the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery using robotic devices can result in a decline in treatment costs and drive the growth of the global robot-assisted surgical devices (RASD) market.
Read More
24 Jun 2022
Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests
Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions.
Read More
23 Jun 2022
Hospital Microbiology Testing Market Driven by Increasing Prevalence of Chronic Diseases
Rising medical expenditure as well as the presence of well-established modern healthcare infrastructure in various developed as well as developing regions is fueling the growth of the global hospital microbiology testing market.
Read More
22 Jun 2022
Global Minimally Invasive Surgery (MIS) Market to Surpass USD 325 Billion by 2031
The global MIS market is projected to surpass USD 325 billion by 2031, driven by growing patient awareness of the advantages of MIS over open surgeries, continuous innovation in surgical robots, and constant advancements in other MIS-associated technologies during the 2022-2031 forecast period.
Read More
21 Jun 2022
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
Medix Biochemica (Espoo, Finland) has acquired 100% of the shares of Bioresource Technology (BRT, Weston, FL, USA) to broaden its base matrix capabilities and further strengthen its local presence in the US market.
Read More
21 Jun 2022
Global Bedside Testing Market to Witness Promising Prospects in Critical Care
Point-of-care or point-of-use diagnostics, also known as bedside testing, has gained increased prominence in analytical testing over the past few years as it provides clinically relevant information without the need for a dedicated laboratory.
Read More
20 Jun 2022
Global Sepsis Diagnostics Market Driven by Rising Hospital-Acquired Illnesses
The global sepsis diagnostics market is expected to grow at a CAGR of 8.3% during the period 2022-2028 to reach almost USD 0.88 billion by 2028, driven by a rise in the number of hospital-acquired illnesses and the rapidly growing molecular diagnostics market, although the high cost of automated diagnostic instruments could hamper market growth.
Read More
14 Jun 2022
BD Partners with Mayo Clinic Platform for Access to World's Largest Collection of Clinical Data
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has entered into a collaboration with Mayo Clinic Platform (Rochester, MN, USA) to access de-identified patient data from Mayo Clinic Platform_Discover.
Read More
14 Jun 2022
Quidel Partners with Global Lyme Alliance, Leads in Lyme Disease Testing
Quidel Corporation (San Diego, CA, USA) is joining forces with Global Lyme Alliance (Stamford, CT, USA) to heighten public awareness around Lyme disease during Lyme Disease Awareness Month (in May) and beyond.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions